Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415 (1988).

Article  CAS  PubMed  Google Scholar 

Sakurai, T. et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348, 732–735 (1990).

Article  CAS  PubMed  Google Scholar 

Arai, H., Hori, S., Aramori, I., Ohkubo, H. & Nakanishi, S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730–732 (1990).

Article  CAS  PubMed  Google Scholar 

Davenport, A. P. et al. Endothelin. Pharmacol. Rev. 68, 357–418 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Kohan, D. E., Rossi, N. F., Inscho, E. W. & Pollock, D. M. Regulation of blood pressure and salt homeostasis by endothelin. Physiol. Rev. 91, 1–77 (2011).

Article  CAS  PubMed  Google Scholar 

Karet, F. & Davenport, A. Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J. Cardiovasc. Pharmacol. 26, S268–S271 (1995).

Article  CAS  PubMed  Google Scholar 

Karet, F. E., Kuc, R. E. & Davenport, A. P. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int. 44, 36–42 (1993).

Article  CAS  PubMed  Google Scholar 

Kohan, D. E. & Barton, M. Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int. 86, 896–904 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Zeeuw, D. et al. The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy. J. Am. Soc. Nephrol. 25, 1083–1093 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Heerspink, H. J. L. et al. Atrasentan in patients with IgA nephropathy. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2409415 (2024).

Heerspink, H. J. L. et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet 393, 1937–1947 (2019).

Article  CAS  PubMed  Google Scholar 

Trachtman, H. et al. DUET: a phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS. J. Am. Soc. Nephrol. 29, 2745–2754 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heerspink, H. J. L. et al. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. Lancet 401, 1584–1594 (2023).

Article  CAS  PubMed  Google Scholar 

Rovin, B. H. et al. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet 402, 2077–2090 (2023).

Article  CAS  PubMed  Google Scholar 

Kedzierski, R. M. & Yanagisawa, M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41, 851–876 (2001).

Article  CAS  PubMed  Google Scholar 

Goddard, J. et al. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure. Circulation 109, 1186–1193 (2004).

Article  CAS  PubMed  Google Scholar 

Goddard, J. et al. Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism. J. Am. Soc. Nephrol. 15, 2601–2610 (2004).

Article  CAS  PubMed  Google Scholar 

Dhaun, N. et al. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. Hypertension 57, 772–779 (2011).

Article  CAS  PubMed  Google Scholar 

Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608–1621 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rabelink, T. J. et al. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease. Nat. Rev. Nephrol. 13, 201–212 (2017).

Article  CAS  PubMed  Google Scholar 

Ebefors, K. et al. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells. Kidney Int. 96, 957–970 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garsen, M. et al. Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx. J. Am. Soc. Nephrol. 27, 3545–3551 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barton, M. & Sorokin, A. Endothelin and the glomerulus in chronic kidney disease. Semin. Nephrol. 35, 156–167 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sorokin, A. & Kohan, D. E. Physiology and pathology of endothelin-1 in renal mesangium. Am. J. Physiol. Renal Physiol. 285, 579–589 (2003).

Article  Google Scholar 

Simonson, M. S. & Ismail-Beigi, F. Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J. Biol. Chem. 286, 11003–11008 (2011).

Article  CAS  PubMed  Google Scholar 

Komers, R. & Plotkin, H. Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R877–884 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Benigni, A. Tubulointerstitial disease mediators of injury: the role of endothelin. Nephrol. Dial. Transplant. 15, 50–52 (2000).

Article  CAS  PubMed  Google Scholar 

Lehrke, I., Waldherr, R., Ritz, E. & Wagner, J. Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria. J. Am. Soc. Nephrol. 12, 2321–2329 (2001).

Article  CAS  PubMed  Google Scholar 

Gerstung, M., Roth, T., Dienes, H. P., Licht, C. & Fries, J. W. U. Endothelin-1 induces NF-κB via two independent pathways in human renal tubular epithelial cells. Am. J. Nephrol. 27, 294–300 (2007).

Article  CAS  PubMed  Google Scholar 

Zoja, C. et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am. J. Kidney Dis. 26, 934–941 (1995).

Article  CAS  PubMed  Google Scholar 

Zager, R. A., Johnson, A. C. M., Andress, D. & Becker, K. Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury. Kidney Int. 84, 703–712 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai, K. N. et al. IgA nephropathy. Nat. Rev. Dis. Prim. 2, 1–20 (2016).